Construction And Real Estate Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Lactulose (A06ad11) as Part of a So-Called...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Fampridine (N07xx07) as Part of a So-Called...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Multienzymes (Lipase, Protease, Etc.) (Atc Code: A09aa02).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Etanercept (Atc Code: L04ab01)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Cyanocobalamin (B03ba01) as Part of a So-Ca...

Dsp Delivery of Medical Devices for Neurosurgery for the Umbal "St. Ivan Rilski" Ead

Open House Contract Dressing Materials

Terminal Bloomberg

Conclusion not Excluding am Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Fusidic Acid (Atc Code According to Who: D06ax01)

International Research Scientist Development Award (irsda) (k01 Independent Clinical Trial Required)